{"transactions":[{"id":777215,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-15T22:26:32.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":62264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual non-employee director award of restricted share units granted pursuant to the Clarivate Plc Amended and Restated 2019 Incentive Award Plan."}],"balance_after":170601,"source":{"system":"sec-edgar","filing":"0001764046-26-000069","document":"wk-form4_1778883990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404626000069/wk-form4_1778883990.xml","form_type":"4"}},{"id":777214,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-15T22:26:32.000Z","date":"2026-05-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":8178,"price":2.44,"value":19954.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for taxes."}],"balance_after":108337,"source":{"system":"sec-edgar","filing":"0001764046-26-000069","document":"wk-form4_1778883990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404626000069/wk-form4_1778883990.xml","form_type":"4"}},{"id":1084100,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-07-21T23:39:29.000Z","date":"2025-07-21","kind":"exercise","planned":true,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":150000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-01","underlying":"Ordinary Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001847903-25-000119","document":"wk-form4_1753141162.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000119/wk-form4_1753141162.xml","form_type":"4"}},{"id":1084099,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-21T23:39:29.000Z","date":"2025-07-21","kind":"sale","planned":true,"acquired":false,"shares":55000,"price":15.92,"value":875600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.80 to $16.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":221017,"source":{"system":"sec-edgar","filing":"0001847903-25-000119","document":"wk-form4_1753141162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000119/wk-form4_1753141162.xml","form_type":"4"}},{"id":1084098,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-21T23:39:29.000Z","date":"2025-07-21","kind":"exercise","planned":true,"acquired":true,"shares":55000,"price":3.85,"value":211750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":276017,"source":{"system":"sec-edgar","filing":"0001847903-25-000119","document":"wk-form4_1753141162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000119/wk-form4_1753141162.xml","form_type":"4"}},{"id":1105126,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-06-21T00:58:59.000Z","date":"2025-06-20","kind":"exercise","planned":true,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":205000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-01","underlying":"Ordinary Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001847903-25-000095","document":"wk-form4_1750467532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000095/wk-form4_1750467532.xml","form_type":"4"}},{"id":1105125,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-06-21T00:58:59.000Z","date":"2025-06-20","kind":"sale","planned":true,"acquired":false,"shares":55000,"price":12.6332,"value":694826.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":221017,"source":{"system":"sec-edgar","filing":"0001847903-25-000095","document":"wk-form4_1750467532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000095/wk-form4_1750467532.xml","form_type":"4"}},{"id":1105124,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-06-21T00:58:59.000Z","date":"2025-06-20","kind":"exercise","planned":true,"acquired":true,"shares":55000,"price":3.85,"value":211750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":276017,"source":{"system":"sec-edgar","filing":"0001847903-25-000095","document":"wk-form4_1750467532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000095/wk-form4_1750467532.xml","form_type":"4"}},{"id":1140589,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-05-20T21:44:05.000Z","date":"2025-05-20","kind":"exercise","planned":true,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":260000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-01","underlying":"Ordinary Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001847903-25-000076","document":"wk-form4_1747777437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000076/wk-form4_1747777437.xml","form_type":"4"}},{"id":1140588,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-05-20T21:44:05.000Z","date":"2025-05-20","kind":"sale","planned":true,"acquired":false,"shares":55000,"price":12.7111,"value":699110.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.265 to $13.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":221017,"source":{"system":"sec-edgar","filing":"0001847903-25-000076","document":"wk-form4_1747777437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000076/wk-form4_1747777437.xml","form_type":"4"}},{"id":1140587,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-05-20T21:44:05.000Z","date":"2025-05-20","kind":"exercise","planned":true,"acquired":true,"shares":55000,"price":3.85,"value":211750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":276017,"source":{"system":"sec-edgar","filing":"0001847903-25-000076","document":"wk-form4_1747777437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000076/wk-form4_1747777437.xml","form_type":"4"}},{"id":1155177,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-09T01:02:34.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":39473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual non-employee director award of restricted share units granted pursuant to the Clarivate Plc 2019 Incentive Award Plan."}],"balance_after":116515,"source":{"system":"sec-edgar","filing":"0001764046-25-000075","document":"wk-form4_1746752548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404625000075/wk-form4_1746752548.xml","form_type":"4"}},{"id":1155176,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-09T01:02:34.000Z","date":"2025-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":4974,"price":4.17,"value":20741.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for taxes."}],"balance_after":77042,"source":{"system":"sec-edgar","filing":"0001764046-25-000075","document":"wk-form4_1746752548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404625000075/wk-form4_1746752548.xml","form_type":"4"}},{"id":1167779,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-04-22T21:43:14.000Z","date":"2025-04-22","kind":"sale","planned":true,"acquired":false,"shares":40344,"price":12.43,"value":501475.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":221017,"source":{"system":"sec-edgar","filing":"0001847903-25-000055","document":"wk-form4_1745358187.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000055/wk-form4_1745358187.xml","form_type":"4"}},{"id":1167778,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-04-22T21:43:14.000Z","date":"2025-04-21","kind":"sale","planned":true,"acquired":false,"shares":14656,"price":12.2885,"value":180100.256,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":261361,"source":{"system":"sec-edgar","filing":"0001847903-25-000055","document":"wk-form4_1745358187.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000055/wk-form4_1745358187.xml","form_type":"4"}},{"id":1194734,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-21T20:53:35.000Z","date":"2025-03-20","kind":"sale","planned":true,"acquired":false,"shares":55000,"price":16.692,"value":918060.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.35 to $17.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":276017,"source":{"system":"sec-edgar","filing":"0001847903-25-000045","document":"wk-form4_1742590408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000045/wk-form4_1742590408.xml","form_type":"4"}},{"id":1222942,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:17:13.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":58275,"price":4.36,"value":254079.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The prices actually paid ranged from $4.31 to $4.43, inclusive.  The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":82016,"source":{"system":"sec-edgar","filing":"0001764046-25-000026","document":"wk-form4_1741209422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404625000026/wk-form4_1741209422.xml","form_type":"4"}},{"id":1256056,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-20T22:45:11.000Z","date":"2025-02-20","kind":"sale","planned":true,"acquired":false,"shares":775,"price":16.5426,"value":12820.515,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.54 to $16.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":331017,"source":{"system":"sec-edgar","filing":"0001847903-25-000035","document":"wk-form4_1740091504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000035/wk-form4_1740091504.xml","form_type":"4"}},{"id":1256055,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-20T22:45:11.000Z","date":"2025-02-20","kind":"sale","planned":true,"acquired":false,"shares":54225,"price":15.9201,"value":863267.4225,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.52 to $16.505, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":331792,"source":{"system":"sec-edgar","filing":"0001847903-25-000035","document":"wk-form4_1740091504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000035/wk-form4_1740091504.xml","form_type":"4"}},{"id":1285159,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-02-04T21:56:32.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":900000,"derivative":{"exercise_price":16.9,"expiration_date":"2035-02-03","underlying":"Ordinary Shares","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001847903-25-000027","document":"wk-form4_1738706184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000027/wk-form4_1738706184.xml","form_type":"4"}},{"id":1285158,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-04T21:56:32.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":43381,"price":16.92,"value":734006.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":386017,"source":{"system":"sec-edgar","filing":"0001847903-25-000027","document":"wk-form4_1738706184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000027/wk-form4_1738706184.xml","form_type":"4"}},{"id":1297804,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-22T21:15:47.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":1625,"price":16.1937,"value":26314.7625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.16 to $16.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":429398,"source":{"system":"sec-edgar","filing":"0001847903-25-000011","document":"wk-form4_1737580539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000011/wk-form4_1737580539.xml","form_type":"4"}},{"id":1297803,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-22T21:15:47.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":53375,"price":15.7586,"value":841115.275,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.16 to $16.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":431023,"source":{"system":"sec-edgar","filing":"0001847903-25-000011","document":"wk-form4_1737580539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790325000011/wk-form4_1737580539.xml","form_type":"4"}},{"id":1319895,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-12-31T21:31:22.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":36263,"price":16.35,"value":592900.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":484398,"source":{"system":"sec-edgar","filing":"0001847903-24-000199","document":"wk-form4_1735680675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000199/wk-form4_1735680675.xml","form_type":"4"}},{"id":1324265,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-12-20T22:22:30.000Z","date":"2024-12-20","kind":"sale","planned":true,"acquired":false,"shares":55000,"price":17.4374,"value":959057.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.12 to $17.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":520661,"source":{"system":"sec-edgar","filing":"0001847903-24-000186","document":"wk-form4_1734733345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000186/wk-form4_1734733345.xml","form_type":"4"}},{"id":1340605,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-12-06T22:03:42.000Z","date":"2024-12-06","kind":"exercise","planned":true,"acquired":false,"shares":87496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3869485,"derivative":{"exercise_price":5.84,"expiration_date":"2031-02-19","underlying":"Ordinary Shares","underlying_shares":87496},"source":{"system":"sec-edgar","filing":"0001847903-24-000178","document":"wk-form4_1733522614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000178/wk-form4_1733522614.xml","form_type":"4"}},{"id":1340604,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-12-06T22:03:42.000Z","date":"2024-12-06","kind":"sale","planned":true,"acquired":false,"shares":87496,"price":18.4609,"value":1615254.9064,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.23 to $18.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":575661,"source":{"system":"sec-edgar","filing":"0001847903-24-000178","document":"wk-form4_1733522614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000178/wk-form4_1733522614.xml","form_type":"4"}},{"id":1340603,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-12-06T22:03:42.000Z","date":"2024-12-06","kind":"exercise","planned":true,"acquired":true,"shares":87496,"price":5.84,"value":510976.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":663157,"source":{"system":"sec-edgar","filing":"0001847903-24-000178","document":"wk-form4_1733522614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000178/wk-form4_1733522614.xml","form_type":"4"}},{"id":1349598,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-11-27T21:22:25.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":false,"shares":299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3956981,"derivative":{"exercise_price":5.84,"expiration_date":"2031-02-19","underlying":"Ordinary Shares","underlying_shares":299},"source":{"system":"sec-edgar","filing":"0001847903-24-000175","document":"wk-form4_1732742538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000175/wk-form4_1732742538.xml","form_type":"4"}},{"id":1349597,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-27T21:22:25.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":299,"price":18.23,"value":5450.77,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."}],"balance_after":575661,"source":{"system":"sec-edgar","filing":"0001847903-24-000175","document":"wk-form4_1732742538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000175/wk-form4_1732742538.xml","form_type":"4"}},{"id":1349596,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-27T21:22:25.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":true,"shares":299,"price":5.84,"value":1746.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":575960,"source":{"system":"sec-edgar","filing":"0001847903-24-000175","document":"wk-form4_1732742538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000175/wk-form4_1732742538.xml","form_type":"4"}},{"id":1354623,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-11-22T22:06:07.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":false,"shares":1671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3957280,"derivative":{"exercise_price":5.84,"expiration_date":"2031-02-19","underlying":"Ordinary Shares","underlying_shares":1671},"source":{"system":"sec-edgar","filing":"0001847903-24-000171","document":"wk-form4_1732313158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000171/wk-form4_1732313158.xml","form_type":"4"}},{"id":1354622,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-11-22T22:06:07.000Z","date":"2024-11-21","kind":"exercise","planned":false,"acquired":false,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3958951,"derivative":{"exercise_price":5.84,"expiration_date":"2031-02-19","underlying":"Ordinary Shares","underlying_shares":3511},"source":{"system":"sec-edgar","filing":"0001847903-24-000171","document":"wk-form4_1732313158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000171/wk-form4_1732313158.xml","form_type":"4"}},{"id":1354621,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-22T22:06:07.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":1671,"price":18.2396,"value":30478.3716,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on  May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.23 to $18.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":575661,"source":{"system":"sec-edgar","filing":"0001847903-24-000171","document":"wk-form4_1732313158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000171/wk-form4_1732313158.xml","form_type":"4"}},{"id":1354620,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-22T22:06:07.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":true,"shares":1671,"price":5.84,"value":9758.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":577332,"source":{"system":"sec-edgar","filing":"0001847903-24-000171","document":"wk-form4_1732313158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000171/wk-form4_1732313158.xml","form_type":"4"}},{"id":1354619,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-22T22:06:07.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":3511,"price":18.2365,"value":64028.3515,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on  May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.23 to $18.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":575661,"source":{"system":"sec-edgar","filing":"0001847903-24-000171","document":"wk-form4_1732313158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000171/wk-form4_1732313158.xml","form_type":"4"}},{"id":1354618,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-22T22:06:07.000Z","date":"2024-11-21","kind":"exercise","planned":false,"acquired":true,"shares":3511,"price":5.84,"value":20504.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":579172,"source":{"system":"sec-edgar","filing":"0001847903-24-000171","document":"wk-form4_1732313158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000171/wk-form4_1732313158.xml","form_type":"4"}},{"id":1354617,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-22T22:06:07.000Z","date":"2024-11-20","kind":"sale","planned":false,"acquired":false,"shares":55000,"price":16.8858,"value":928719.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on  May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.48 to $17.315, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":575661,"source":{"system":"sec-edgar","filing":"0001847903-24-000171","document":"wk-form4_1732313158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000171/wk-form4_1732313158.xml","form_type":"4"}},{"id":1363919,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-11-15T21:30:47.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":false,"shares":32023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3962462,"derivative":{"exercise_price":5.84,"expiration_date":"2031-02-19","underlying":"Ordinary Shares","underlying_shares":32023},"source":{"system":"sec-edgar","filing":"0001847903-24-000169","document":"wk-form4_1731706240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000169/wk-form4_1731706240.xml","form_type":"4"}},{"id":1363918,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-15T21:30:47.000Z","date":"2024-11-13","kind":"sale","planned":true,"acquired":false,"shares":32023,"price":18.2812,"value":585418.8676,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.23 to $18.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":630661,"source":{"system":"sec-edgar","filing":"0001847903-24-000169","document":"wk-form4_1731706240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000169/wk-form4_1731706240.xml","form_type":"4"}},{"id":1363917,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-15T21:30:47.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":true,"shares":32023,"price":5.84,"value":187014.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":662684,"source":{"system":"sec-edgar","filing":"0001847903-24-000169","document":"wk-form4_1731706240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000169/wk-form4_1731706240.xml","form_type":"4"}},{"id":1382405,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-10-23T21:27:22.000Z","date":"2024-10-23","kind":"sale","planned":true,"acquired":false,"shares":2592,"price":15.3151,"value":39696.7392,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.09 to $15.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":630661,"source":{"system":"sec-edgar","filing":"0001847903-24-000160","document":"wk-form4_1729718836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000160/wk-form4_1729718836.xml","form_type":"4"}},{"id":1382404,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-10-23T21:27:22.000Z","date":"2024-10-22","kind":"sale","planned":true,"acquired":false,"shares":30203,"price":15.6663,"value":473169.2589,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.27 to $16.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":633253,"source":{"system":"sec-edgar","filing":"0001847903-24-000160","document":"wk-form4_1729718836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000160/wk-form4_1729718836.xml","form_type":"4"}},{"id":1382403,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-10-23T21:27:22.000Z","date":"2024-10-21","kind":"sale","planned":true,"acquired":false,"shares":22205,"price":15.801,"value":350861.205,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.625 to $16.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":663456,"source":{"system":"sec-edgar","filing":"0001847903-24-000160","document":"wk-form4_1729718836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000160/wk-form4_1729718836.xml","form_type":"4"}},{"id":1394709,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-10-02T20:31:26.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":36263,"price":15.79,"value":572592.77,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":685661,"source":{"system":"sec-edgar","filing":"0001847903-24-000154","document":"wk-form4_1727901077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000154/wk-form4_1727901077.xml","form_type":"4"}},{"id":1401683,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-20T20:55:12.000Z","date":"2024-09-20","kind":"sale","planned":true,"acquired":false,"shares":55000,"price":16.527,"value":908985.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.28 to $16.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":721924,"source":{"system":"sec-edgar","filing":"0001847903-24-000145","document":"wk-form4_1726865706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000145/wk-form4_1726865706.xml","form_type":"4"}},{"id":1408764,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-09-13T00:01:07.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3994485,"derivative":{"exercise_price":5.84,"expiration_date":"2031-02-19","underlying":"Ordinary Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001847903-24-000142","document":"wk-form4_1726185660.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000142/wk-form4_1726185660.xml","form_type":"4"}},{"id":1408763,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-13T00:01:07.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":175000,"price":16.5247,"value":2891822.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.23 to $17.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":776924,"source":{"system":"sec-edgar","filing":"0001847903-24-000142","document":"wk-form4_1726185660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000142/wk-form4_1726185660.xml","form_type":"4"}},{"id":1408762,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-13T00:01:07.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":true,"shares":175000,"price":5.84,"value":1022000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":951924,"source":{"system":"sec-edgar","filing":"0001847903-24-000142","document":"wk-form4_1726185660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000142/wk-form4_1726185660.xml","form_type":"4"}},{"id":1415973,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-09-04T20:51:49.000Z","date":"2024-08-30","kind":"sale","planned":false,"acquired":false,"shares":17646,"price":6.75,"value":119110.5,"ownership":{"direct":true},"balance_after":23741,"source":{"system":"sec-edgar","filing":"0001764046-24-000122","document":"wk-form4_1725481722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404624000122/wk-form4_1725481722.xml","form_type":"4"}},{"id":1424414,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-23T21:13:13.000Z","date":"2024-08-23","kind":"sale","planned":true,"acquired":false,"shares":46651,"price":12.3021,"value":573905.2671,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":776924,"source":{"system":"sec-edgar","filing":"0001847903-24-000137","document":"wk-form4_1724447584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000137/wk-form4_1724447584.xml","form_type":"4"}},{"id":1425574,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-22T21:15:29.000Z","date":"2024-08-22","kind":"sale","planned":true,"acquired":false,"shares":506,"price":12.23,"value":6188.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."}],"balance_after":823575,"source":{"system":"sec-edgar","filing":"0001847903-24-000131","document":"wk-form4_1724361323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000131/wk-form4_1724361323.xml","form_type":"4"}},{"id":1425573,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-22T21:15:29.000Z","date":"2024-08-21","kind":"sale","planned":true,"acquired":false,"shares":3674,"price":12.2453,"value":44989.2322,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":824081,"source":{"system":"sec-edgar","filing":"0001847903-24-000131","document":"wk-form4_1724361323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000131/wk-form4_1724361323.xml","form_type":"4"}},{"id":1425572,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-22T21:15:29.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":4169,"price":12.3215,"value":51368.3335,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":827755,"source":{"system":"sec-edgar","filing":"0001847903-24-000131","document":"wk-form4_1724361323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000131/wk-form4_1724361323.xml","form_type":"4"}},{"id":1463336,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-07-02T20:32:01.000Z","date":"2024-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":36263,"price":9.03,"value":327454.89,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":831924,"source":{"system":"sec-edgar","filing":"0001847903-24-000116","document":"wk-form4_1719952312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000116/wk-form4_1719952312.xml","form_type":"4"}},{"id":1523473,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-08T20:34:50.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":23741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual non-employee director award of restricted share units granted pursuant to the Clarivate Plc 2019 Incentive Award Plan."}],"balance_after":41387,"source":{"system":"sec-edgar","filing":"0001764046-24-000074","document":"wk-form4_1715200474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404624000074/wk-form4_1715200474.xml","form_type":"4"}},{"id":1523472,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-08T20:34:50.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":4412,"price":7.05,"value":31104.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for taxes."}],"balance_after":17646,"source":{"system":"sec-edgar","filing":"0001764046-24-000074","document":"wk-form4_1715200474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404624000074/wk-form4_1715200474.xml","form_type":"4"}},{"id":1553881,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-04-02T20:17:36.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":36263,"price":11.3,"value":409771.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":868187,"source":{"system":"sec-edgar","filing":"0001847903-24-000062","document":"wk-form4_1712089043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000062/wk-form4_1712089043.xml","form_type":"4"}},{"id":1662076,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-02-02T22:07:11.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":576800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":576800,"derivative":{"exercise_price":8.01,"expiration_date":"2034-02-01","underlying":"Ordinary Shares","underlying_shares":576800},"source":{"system":"sec-edgar","filing":"0001847903-24-000033","document":"wk-form4_1706911620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000033/wk-form4_1706911620.xml","form_type":"4"}},{"id":1662075,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-02T22:07:11.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":26323,"price":8.19,"value":215585.37,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":904450,"source":{"system":"sec-edgar","filing":"0001847903-24-000033","document":"wk-form4_1706911620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000033/wk-form4_1706911620.xml","form_type":"4"}},{"id":1662074,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-02T22:07:11.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":144200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares reported in this transaction represent Restricted Share Units (\"RSUs\") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2025."}],"balance_after":930773,"source":{"system":"sec-edgar","filing":"0001847903-24-000033","document":"wk-form4_1706911620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000033/wk-form4_1706911620.xml","form_type":"4"}},{"id":1696654,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2024-01-03T00:43:04.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":36263,"price":7.96,"value":288653.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":786573,"source":{"system":"sec-edgar","filing":"0001847903-24-000013","document":"wk-form4_1704242572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790324000013/wk-form4_1704242572.xml","form_type":"4"}},{"id":1767843,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2023-10-03T20:53:01.000Z","date":"2023-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":36263,"price":6.47,"value":234621.61,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":822836,"source":{"system":"sec-edgar","filing":"0001847903-23-000173","document":"wk-form4_1696366367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790323000173/wk-form4_1696366367.xml","form_type":"4"}},{"id":1839832,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2023-07-03T21:32:46.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":36263,"price":5.9001,"value":213955.3263,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":859099,"source":{"system":"sec-edgar","filing":"0001847903-23-000143","document":"wf-form4_168841995588866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790323000143/wf-form4_168841995588866.xml","form_type":"4"}},{"id":1901109,"issuer":{"id":4778,"kind":"organization","name":"CLARIVATE PLC","symbol":"CLVT"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-08T21:10:45.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":22058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award of restricted share units granted pursuant to the Clarivate Plc 2019 Incentive Award Plan."}],"balance_after":22058,"source":{"system":"sec-edgar","filing":"0001764046-23-000052","document":"wf-form4_168358023091755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000176404623000052/wf-form4_168358023091755.xml","form_type":"4"}},{"id":1928870,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2023-04-04T21:03:59.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":22013,"price":3.9,"value":85850.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":895362,"source":{"system":"sec-edgar","filing":"0001847903-23-000084","document":"wf-form4_168064221788697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790323000084/wf-form4_168064221788697.xml","form_type":"4"}},{"id":2033346,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-02-03T22:10:58.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":315000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":315000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-02-01","underlying":"Ordinary Shares","underlying_shares":315000},"source":{"system":"sec-edgar","filing":"0001847903-23-000047","document":"wf-form4_167546223542666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790323000047/wf-form4_167546223542666.xml","form_type":"4"}},{"id":2033345,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2023-02-03T22:10:58.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":211400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares reported in this transaction represent Restricted Share Units (\"RSUs\") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2024."}],"balance_after":917375,"source":{"system":"sec-edgar","filing":"0001847903-23-000047","document":"wf-form4_167546223542666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790323000047/wf-form4_167546223542666.xml","form_type":"4"}},{"id":2068488,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-05T00:25:04.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":44025,"price":3.1,"value":136477.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units."}],"balance_after":705975,"source":{"system":"sec-edgar","filing":"0001847903-23-000013","document":"wf-form4_167287828844971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000184790323000013/wf-form4_167287828844971.xml","form_type":"4"}},{"id":2212242,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-06T22:16:07.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares reported in this transaction represent Restricted Share Units (\"RSUs\") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in 10 equal quarterly instalments with the first such quarterly vesting being on September 30, 2022."}],"balance_after":750000,"source":{"system":"sec-edgar","filing":"0000899243-22-025478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000089924322025478/doc4.xml","form_type":"4"}},{"id":2221343,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-06-28T01:28:14.000Z","date":"2022-06-24","kind":"purchase","acquired":true,"shares":10000,"price":4.6284,"value":46284.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.6000 to $4.6495, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0000899243-22-024303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000089924322024303/doc4.xml","form_type":"4"}},{"id":2411841,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-04T13:30:10.000Z","date":"2022-02-02","kind":"purchase","acquired":true,"shares":5000,"price":9.74,"value":48700.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.65 to $9.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0000899243-22-004782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000089924322004782/doc4.xml","form_type":"4"}},{"id":2414358,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2022-02-03T23:30:21.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":750000,"derivative":{"exercise_price":9.53,"expiration_date":"2032-02-01","underlying":"Ordinary Shares","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0000899243-22-004681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000089924322004681/doc4.xml","form_type":"4"}},{"id":2505105,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":46935,"kind":"person","name":"SAHA SAURABH","position":1,"cik":"0001861926","reported_name":"SAHA SAURABH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-19T00:00:34.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":23000,"price":12.2814,"value":282472.2,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.95 to $12.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0000899243-21-045311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861926/000089924321045311/doc4.xml","form_type":"4"}}]}